Calendar Arcturus Therapeutics Holdings Inc.

Equities

ARCT

US03969T1097

Market Closed - Nasdaq 04:00:00 2024-02-27 pm EST 5-day change 1st Jan Change
42.99 USD +5.01% Intraday chart for Arcturus Therapeutics Holdings Inc. +18.72% +36.35%

Chart calendar Arcturus Therapeutics Holdings Inc.

b4f942edc9c99927082.UgO0xCD44BRw90DCH95c8XAfvjL1F31J8fW2vEZTEhM.H3n3vWnLsFkBqASyT-oGsgcr82KUXQQQgpTd8j9jW3UFUMSqT7GMfAC6AQ~e42975f4f3243de955b93718e014945a

Upcoming events on Arcturus Therapeutics Holdings Inc.

2024-05-05 Q1 2024 Earnings Release (Projected)
2024-08-04 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)

Past events on Arcturus Therapeutics Holdings Inc.

2024-02-25 Q4 2023 Earnings Release (Projected)
2024-01-09 06:00 pm JPMorgan Healthcare Conference
2023-11-28 08:30 am Piper Sandler Healthcare Conference
2023-11-14 04:30 pm Q3 2023 Earnings Call
2023-11-14 04:01 pm Q3 2023 Earnings Release
2023-11-07 09:10 am Guggenheim Securities Inflammation & Immunology Conference
2023-11-01 05:42 am International mRNA Health Conference
2023-10-01 Chardan Genetic Medicines Conference
2023-09-27 10:55 am Cantor Global Healthcare Conference
2023-09-12 03:10 pm Baird Global Healthcare Conference
2023-09-11 08:30 am H.C. Wainwright Global Investment Conference
2023-09-07 01:30 pm Wells Fargo Healthcare Conference
2023-09-06 04:20 pm Citi BioPharma Conference
2023-08-09 09:30 am Canaccord Genuity Growth Conference
2023-08-07 04:30 pm Q2 2023 Earnings Call
2023-08-07 04:01 pm Q2 2023 Earnings Release
2023-06-14 12:00 pm Annual General Meeting
2023-05-09 04:30 pm Q1 2023 Earnings Call
2023-05-09 04:01 pm Q1 2023 Earnings Release
2023-04-03 02:10 pm Guggenheim Genomic Medicines and Rare Disease Day

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
15,8
11,5
37.35%
20,8
21,7
-4.14%
9,54
9,74
-2.02%
12,4
21,3
-42.08%
206
140
47.16%

174

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
-202
-202
-0.07%
13,7
-60,9
122.49%

-106

EBIT
Million USD
Released
Forecast
Spread
-21,8
-25,9
15.83%
-25,5
-22,5
-13.45%
-71,5
-63,0
-13.54%
-203
-209
3.17%
12,2
-67,7
117.99%

-88,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-21,8
-25,7
15.33%
-26,0
-22,8
-14.14%
-72,1
-63,6
-13.47%
-204
-210
3.07%
10,6
-67,4
115.79%

-37,2

Net income
Million USD
Released
Forecast
Spread
-21,8
-25,7
15.33%
-26,0
-22,8
-14.14%
-72,1
-63,5
-13.69%
-204
-211
3.62%
9,35
-67,4
113.86%

-42,5

EPS
USD
Released
Forecast
Spread
-2,16
-2,54
14.83%
-2,15
-1,80
-19.56%
-3,55
-3,08
-15.4%
-7,74
-7,90
2%
0,35
-2,99
111.7%

-1,53

Announcement Date18/03/1911/03/2001/03/2128/02/2228/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
2,44
19,2
-87.31%
5,79
11,6
-50.25%
5,24
7,08
-25.96%
27,1
3,14
763.69%
13,4
4,09
226.68%
160
80,5
99.08%
80,3
60,5
32.68%
10,5
49,3
-78.67%
45,1
15,9
184.53%

37,9


29,4


33,8


52,4


63,2

EBITDA
Million USD
Released
Forecast
Spread




























-57,4


-43,8


-18,7


-19,8




EBIT
Million USD
Released
Forecast
Spread
-53,8
-42,6
-26.28%
-37,6
-47,4
20.51%
-50,4
-38,3
-31.37%
-22,1
-48,7
54.64%
-36,8
-47,7
22.91%
121
27,3
344.94%
14,8
-4,63
418.5%
-55,4
-10,1
-449.24%
-19,3
-45,7
57.78%

-23,8


-31,8


-26,2


-23,4


-13,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-54,1
-35,7
-51.52%
-38,7
-45,0
14.15%
-51,2
-34,8
-46.85%
-21,6
-49,4
56.39%
-35,3
-45,8
23.05%
119
40,5
193.16%
50,9
16,2
213.35%
-52,0
-5,30
-880.64%
-15,3
-44,6
65.64%

-15,9


-30,1


-29,1


-22,9


-17,1

Net income
Million USD
Released
Forecast
Spread
-54,1
-38,5
-40.55%
-38,7
-46,2
16.39%
-51,2
-34,6
-47.69%
-21,6
-49,4
56.39%
-35,3
-45,8
22.98%
117
40,5
190.06%
50,8
18,8
170.59%
-52,6
-4,34
-1110.48%
-16,2
-43,9
63.07%

-21,4


-27,6


-27,0


-23,1


-13,5

EPS
USD
Released
Forecast
Spread
-2,05
-1,33
-53.62%
-1,47
-1,63
9.57%
-1,94
-1,31
-48.37%
-0,82
-1,86
55.85%
-1,33
-1,77
24.81%
4,33
1,10
294.53%
1,87
0,41
353.88%
-1,98
-0,17
-1039.57%
-0,61
-1,65
62.97%

-0,86


-1,06


-1,02


-0,42


-0,19

Announcement Date08/11/2128/02/2209/05/2209/08/2209/11/2228/03/2309/05/2307/08/2314/11/23-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Arcturus Therapeutics Holdings Inc. - Nasdaq
  4. Calendar Arcturus Therapeutics Holdings Inc.
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW